What is the ROE (Return on Equity) of La Jolla Pharmaceutical this year?
The ROE of La Jolla Pharmaceutical this year is -0.29 undefined.
In 2024, La Jolla Pharmaceutical's return on equity (ROE) was -0.29, a 0% increase from the 0 ROE in the previous year.
La Jolla Pharmaceutical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Analyzing La Jolla Pharmaceutical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
La Jolla Pharmaceutical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Changes in La Jolla Pharmaceutical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
The ROE of La Jolla Pharmaceutical this year is -0.29 undefined.
The ROE of La Jolla Pharmaceutical has increased by 0% decreased compared to the previous year.
A high ROE indicates that La Jolla Pharmaceutical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
A low ROE can indicate that La Jolla Pharmaceutical is having difficulties monetizing its investments successfully and can be a negative signal for investors.
A change in ROE (Return on Equity) of La Jolla Pharmaceutical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Some factors that can influence La Jolla Pharmaceutical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
Over the past 12 months, La Jolla Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, La Jolla Pharmaceutical is expected to pay a dividend of 0 USD.
The current dividend yield of La Jolla Pharmaceutical is .
La Jolla Pharmaceutical pays a quarterly dividend. This is distributed in the months of .
La Jolla Pharmaceutical paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
La Jolla Pharmaceutical is assigned to the 'Health' sector.
To receive the latest dividend of La Jolla Pharmaceutical from 10/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/24/2024.
The last dividend was paid out on 10/24/2024.
In the year 2023, La Jolla Pharmaceutical distributed 0 USD as dividends.
The dividends of La Jolla Pharmaceutical are distributed in USD.
The La Jolla Pharmaceutical stock can be added to a savings plan with the following providers: Trade Republic
Our stock analysis for La Jolla Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of La Jolla Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.